Business / Finance

RSS

Avedro announces completion of $43M Series D financing

Avedro, Inc. announced today the completion of a $43 million Series D financing led by Abingworth along with a significant investment by Third Point.

5 Mar 2013

Acadia proposes $150M in senior unsecured notes due 2021

Acadia Healthcare Company, Inc. today announced that it is proposing to issue $150 million in senior unsecured notes due 2021 in a private offering that is exempt from the registration requirements of the Securities Act of 1933, as amended.

5 Mar 2013

WomanCare Global, Evofem enter strategic alliance

Evofem announced today that it has entered into a strategic alliance with WomanCare Global. Through this alliance, WomanCare Global will provide sales, marketing and global distribution for a selection of Evofem's products, including Softcup and Amphora.

4 Mar 2013

OPKO Health acquires Cytochroma

OPKO Health, Inc. announced that it has completed the acquisition of Cytochroma Inc. Cytochroma's lead products include CTAP101 Capsules, a vitamin D prohormone to treat secondary hyperparathyroidism (SHPT) in patients with stage 3 or 4 chronic kidney disease (CKD) and vitamin D insufficiency, and Fermagate Tablets, a new and potent non-absorbed phosphate binder to treat hyperphosphatemia in CKD patients on chronic hemodialysis.

4 Mar 2013

Nautilus fourth quarter net sales increase 8.4% to $65.0 million

Nautilus, Inc. today reported its unaudited operating results for the fourth quarter and full year ended December 31, 2012.

4 Mar 2013

DBV Technologies total revenues increase to €2,776,588 for full year 2012

DBV Technologies, creator of Viaskin, a new standard in the treatment of allergy, announced today its full year 2012 results, approved by the Board of Directors on March 1st, 2013.

4 Mar 2013

Toshiba to acquire 70% of stock in TI Medical Systems

Toshiba Medical Systems Corporation will acquire 70% of the stock in the Korean company, TI Medical Systems Co., Ltd. held by INFINITT Healthcare Co., Ltd. and establish a wholly owned subsidiary in South Korea.

4 Mar 2013

PDL BioPharma fourth quarter total revenues increase to $86.0 million

PDL BioPharma, Inc. (PDL) today reported financial results for the fourth quarter and full year ended December 31, 2012.

2 Mar 2013

Covalon first quarter revenue decreases 17% to $572,006

Covalon Technologies Ltd., an advanced medical technologies company, today announced financial results for its first quarter ended December 31, 2012.

2 Mar 2013

Wright Medical Group acquires BioMimetic Therapeutics

Wright Medical Group, Inc. today announced that it has completed its acquisition of BioMimetic Therapeutics, Inc. The transaction combines BioMimetic's breakthrough biologics platform and pipeline with Wright's established sales force and product portfolio, to further accelerate growth opportunities in Wright's Extremities business.

1 Mar 2013

EpiCept fourth quarter revenue decreases to $0.1 million

EpiCept Corporation today announced operating and financial results for the fourth quarter and full year ended December 31, 2012, and provided an update on the Company's merger with Immune Pharmaceuticals, Ltd. (Immune).

28 Feb 2013

NanoViricides retires Series C Convertible Preferred Stock previously purchased by Seaside

NanoViricides, Inc., announced today that it has retired the remainder of the Series C Convertible Preferred Stock previously purchased by Seaside 88, LP, with a cash payment.

27 Feb 2013

Global eye health company, Bausch + Lomb, names Robert Bertolini as president and chief financial officer

Bausch + Lomb, the global eye health company, has named Robert Bertolini as president and chief financial officer effective immediately. In this capacity, he will oversee the company's Finance, Information Technology and Global Quality and Operations (GQO) functions. Bertolini, who assumes CFO responsibilities from Brian J. Harris, will report to Bausch + Lomb's chief executive officer, Brent Saunders.

27 Feb 2013

Almost Family reports net service revenues of $87M for fourth quarter

Almost Family, Inc., a leading regional provider of home health nursing and personal care services, announced today its financial results for the three months and full year ended December 31, 2012.

27 Feb 2013

HeartWare International fourth quarter revenue increases 42% to $32.7 million

HeartWare International, Inc., a leading innovator of less invasive, miniaturized circulatory support technologies that are revolutionizing the treatment of advanced heart failure, today announced revenue of $32.7 million for the fourth quarter ended December 31, 2012, a 42% increase compared to $23.1 million in revenue for the same period of 2011.

27 Feb 2013

XBiotech to enter biosimilar business

XBiotech, a privately held biotechnology company, announced today that it is entering the biosimilar business. The Company is launching its biosimilar business with development of two of the world's leading therapeutic antibodies, one an oncology and the other an anti-inflammatory product.

26 Feb 2013

Glide Pharma announces completion of $21.4 million investment round

Glide Pharma, the pharmaceutical development and device company focused on the needle-free administration of solid dose formulations, today announced that it has completed a £14.0 million ($21.4 million) investment round.

26 Feb 2013

Kindred Healthcare fourth quarter consolidated revenues increase 2% to $1.55 billion

Kindred Healthcare, Inc. today announced its operating results for the fourth quarter and year ended December 31, 2012.

25 Feb 2013

Mindray fourth quarter net revenues increase 19.7% to $316.1 million

Mindray Medical International Limited, a leading developer, manufacturer and marketer of medical devices worldwide, announced today its selected unaudited financial results for the fourth quarter and full year ended December 31, 2012.

From Mindray 25 Feb 2013

Next generation deep brain stimulation (DBS) therapy to be developed by Sapiens

Sapiens Steering Brain Stimulation B.V. (Sapiens), an emerging medical technology company developing brain stimulation products, today announced that it has raised €7.5 m from the Dutch investment group INKEF Capital, in a further extension of their Series A financing round. The proceeds will be used for the development of its Steering Brain Stimulation implant and procedure solutions to treat Parkinson's disease (PD) and other functional brain disorders.

25 Feb 2013